Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03417583 · ClinicalTrials.gov registry record · NA
Assessing Efficacy of Neuropsychiatric Assessment and Treatment Protocols in Huntington's Disease Patients
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03417583 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT03417583, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Phase A: Recruit 50 patients with HD, and their caregivers, to complete a neuropsychiatric and quality of life battery of scales at baseline. Have these 50 patients complete a formal psychiatric assessment with a psychiatrist within 2 weeks of this clinical battery, and the results of these 2 types of assessments will be compared to establish the level of agreement between clinical rating scales and formal psychiatric assessment. Phase B: Continue to follow Phase A cohort longitudinally and administer neuropsychiatric and quality of life battery at 6 months, 12 months, and 18 months form baseline. Recruit an additional 50 patients, administer the same neuropsychiatric and quality of life battery at baseline, implement medication and counseling intervention according to a standard of care protocol, and follow up with the same neuropsychiatric and quality of life battery at 6, 12, and 18 months.
Interventions
- OTHER Protocol Intervention Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-11-09 |
| Est. Completion | 2023-10-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03417583
The ClinicalTrials.gov registry entry for NCT03417583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Protocol Intervention Group is the first listed.
NCT03417583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03417583 about?
NCT03417583 is a clinical study titled "Assessing Efficacy of Neuropsychiatric Assessment and Treatment Protocols in Huntington's Disease Patients". Phase A: Recruit 50 patients with HD, and their caregivers, to complete a neuropsychiatric and quality of life battery of scales at baseline. Have these 50 patients complete a formal psychiatric assessment with a psychiatrist within 2 weeks of this clinical battery, and the results of these 2 types ...
What is the current status of trial NCT03417583?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-11-09. Estimated completion is 2023-10-10.
What interventions are being tested in trial NCT03417583?
The interventions under investigation include: Protocol Intervention Group (OTHER).
Who is sponsoring clinical trial NCT03417583?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.